GE HealthCare Technologies
NasdaqGS:GEHC Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 62 Fair Values set on narratives written by author
WA
Consensus Narrative from 21 Analysts
Flyrcado Launch And Sutter Health Alliance Will Fuel Future Growth
Key Takeaways Strategic investments in R&D and successful M&A executions position the company for sustained high-margin revenue growth and stable long-term earnings. Undervalued stock price does not fully reflect the potential revenue growth from robust backlog, productivity improvements, and strategic partnerships.
View narrativeUS$100.05
FV
14.7% undervalued intrinsic discount3.68%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
Updated narrative